Market Closed

LAB
Standard BioTools
$ 0.7074
8.60%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Standard BioTools News

Latest Standard BioTools Stock News & LAB Headlines

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
5 years ago | globenewswire.com
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5 years ago | globenewswire.com
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
5 years ago | globenewswire.com
Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
5 years ago | globenewswire.com
Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022
5 years ago | globenewswire.com
Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY
5 years ago | globenewswire.com
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion
5 years ago | globenewswire.com
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results
5 years ago | globenewswire.com
Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors
5 years ago | globenewswire.com
Fluidigm Corporation: Investment Opportunity
5 years ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

LAB
Standard BioTools
$ 0.7074
8.60%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago